Selected high-performance equipment tailored for Israel's "Kupat Holim" and private clinical labs.
Israel stands at the global forefront of digital health and medical innovation. With a healthcare system built on four primary Health Maintenance Organizations (HMOs)—Clalit, Maccabi, Meuhedet, and Leumit—the demand for decentralized, Point-of-Care (POC) Molecular Diagnostics has seen an unprecedented surge. The Israeli market prioritizes rapid turnaround times, high analytical sensitivity, and seamless integration with Electronic Health Records (EHR).
Moving molecular testing from centralized labs in Tel Aviv and Haifa to community clinics in the Galilee and Negev regions to reduce patient wait times.
Israel's focus on personalized medicine requires robust sequencing and nucleic acid testing (NAT) platforms that can handle diverse genetic profiles.
Deployment of ruggedized POC molecular units for rapid pathogen detection in civilian defense and emergency response scenarios.
As a leading Point-of-Care Molecular Diagnostics Supplier, Shenzhen BioX Medical Co., Ltd. is charting a course toward "Lab-on-a-Chip" miniaturization. Our roadmap for the Israel market includes:
In an era of global logistical uncertainty, BioX Medical utilizes Factory 4.0 principles at our Shenzhen headquarters. This includes automated assembly lines, real-time inventory tracking, and AI-optimized quality control. For our Israeli partners, this translates to:
Rapid scalability to meet sudden surges in demand for diagnostic kits or instrumentation, ensuring no disruption in Israeli patient care.
Strategic proximity to Shenzhen's global shipping hubs allows for expedited delivery to Port of Ashdod and Ben Gurion Airport.
Navigating the regulatory environment in Israel requires expertise in AMAR (Israel Ministry of Health) registration. BioX Medical provides comprehensive technical dossiers, clinical validation data, and ISO 13485 documentation to ensure seamless market entry and compliance with CE-IVDR standards.
Our localization strategy involves partnership with local distributors to provide on-site technical training, Hebrew-language software interfaces, and 24/7 maintenance support for Israeli hospitals.
Israeli medical procurement officers demand more than just competitive pricing; they require Information Gain. Our diagnostic systems offer integrated data management that supports the HL7/FHIR protocols common in Israeli healthcare IT systems. Whether it is for high-throughput laboratory settings or localized point-of-care, our equipment is designed for "plug-and-play" compatibility.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
Yes, our software platforms are customizable and can support Hebrew localization for the Israeli market to ensure ease of use for local healthcare professionals.
We provide all necessary technical documentation and assist our local Israeli partners in obtaining AMAR (Ministry of Health) certifications for all imported medical devices.
Our systems utilize gold-standard molecular amplification technologies and advanced optical detection, achieving >99% correlation with centralized laboratory PCR results.
Standard lead time is 2-4 weeks, depending on order volume. We offer expedited air freight options for urgent clinical needs in the Israel region.
Expanding our reach beyond molecular diagnostics into industrial oxygen, reagents, and advanced filtration.
BioX Medical
